Abstract
Two mechanisms have been suggested by which combinations of drugs may depress the intracellular availability of a given metabolite to a level that becomes limiting for cell survival. Potter1 has applied the term sequential inhibition to the action of two or more inhibitors on different enzymes in a limited portion of a multi-enzyme sequence (equation 1), and Elion, Singer and Hitchings2 have denoted as concurrent blockade the simultaneous retardation, by two or more agents, of alternate biochemical routes to the same end-product (equation 2).
Similar content being viewed by others
References
Potter, V. R. Proc. Soc. Exp. Biol. Med., 76, 41 (1951).
Elion, G. B., Singer, S., and Hitchings, G. H., J. Biol. Chem., 208, 477 (1954).
Karnofsky, D. A., and Clarkson, B. D., Ann. Rev. Pharmacol., 3, 357 (1963).
Brockman, R. W., and Anderson, E. P., Ann. Rev. Biochem., 32, 463 (1963).
Bergel, F., Chemistry of Enzymes in Cancer (Charles C. Thomas, Springfield, Illinois, 1961).
Sartorelli, A. C., Bieber, A. L., Chang, P. K., and Fischer, G. A., Biochem. Pharmacol., 13, 507 (1964).
Booth, B. A., and Sartorelli, A. C., Science, 138, 518 (1962).
Booth, B. A., and Sartorelli, A. C., Cancer Res., 23, 1762 (1963).
Sartorelli, A. C., and Booth, A. C., Proc. Amer. Assoc. Cancer Res., 5, 32 (1964).
Schneider, W. C., in Methods in Enzymology, edit. by Colowick, S. P., and Kaplan, N. O., 3, 680 (Academic Press Inc., New York, 1957).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SARTORELLI, A. Combination Chemotherapy with Actinomycin D and Ribonuclease : an Example of Complementary Inhibition. Nature 203, 877–878 (1964). https://doi.org/10.1038/203877a0
Issue Date:
DOI: https://doi.org/10.1038/203877a0
- Springer Nature Limited
This article is cited by
-
Untersuchungen über die kombinierte cytostatische Therapie
Klinische Wochenschrift (1965)